Skip to main content
Fig. 8 | Journal of Experimental & Clinical Cancer Research

Fig. 8

From: ZIP10 is a negative determinant for anti-tumor effect of mannose in thyroid cancer by activating phosphate mannose isomerase

Fig. 8

A schematic model of mannose killing thyroid cancer cells by inhibiting cellular glycolysis. Mannose enters the cell and converts into mannose-6-phophate which inhibits the enzymes of glycolytic pathway, such as hexokinase and phosphoglucose isomerase, thereby hindering cellular glycolysis. However, when PMI is highly activated by ZIP10-mediated extracellular Zn2+ influx, mannose-6-phosphate can be converted into fructose-6-phosphate by PMI, promoting cellular glycolysis and malignant phenotypes of cancer cells. Thus, ZIP10 is a negative determinant for the response of thyroid cancer cells to mannose

Back to article page